ImmuCell Corp (NASDAQ:ICCC)

7.93
Delayed Data
As of 3:59pm ET
 +0.06 / +0.76%
Today’s Change
3.96
Today|||52-Week Range
8.69
+63.17%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.87
Today’s open7.97
Day’s range7.93 - 7.97
Volume1,115
Average volume (3 months)15,001
Market cap$23.8M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-250.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+26.46%
P/E ratio74.5
Price/Sales1.94
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
CANFCan Fite Biopharma L...0.000.00%
CBMXCombiMatrix Corp+0.02+1.22%
RXIIRxi Pharmaceuticals ...-0.01-1.90%
NSPHNanosphere Inc-0.18-5.47%
Data as of 4:00pm ET, 07/02/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$7.6M
Annual profit (last year)-$167.2K
Net profit margin-2.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, CFO, Secretary &
Treasurer
Michael F. Brigham
Director, Chief Scientific Officer &
VP
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers